Bills

SB 2221: USDA; Terminal Illness; Right-to-Try; Investigative Drug or Biological Product; Access to Care

  • Session Year: 2025-2026
  • House: Senate
  • Latest Version Date: 2026-01-15

Current Status:

Failed

(2026-01-26: Referred to HHS, CPN/JDC.)

Introduced

In Committee

First Chamber

In Committee

Second Chamber

Final Decking

Enacted

Version:

Authorizes manufacturers of investigational drugs or biological products that are pending approval by the United States Food and Drug Administration to make the drugs or products available to terminally ill patients under certain conditions.

Authors shown for version:
SB2221 (1/15/2026)

Bill Author

Bill Co-Author(s):